Cargando…
Long-Term Azithromycin Treatment in Pediatric Primary Ciliary Dyskinesia: A Retrospective Study
OBJECTIVES: Primary ciliary dyskinesia (PCD) is a rare genetic disease mainly involved in lung dysfunction. PCD patient outcomes after azithromycin (AZM) treatment have rarely been reported. This study was aimed to assess AZM treatment effects on disease progression of pediatric PCD patients. STUDY...
Autores principales: | Guan, Yuhong, Zhang, Xiang, Yang, Haiming, Xu, Hui, Zhao, Shunying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226474/ https://www.ncbi.nlm.nih.gov/pubmed/35757125 http://dx.doi.org/10.3389/fped.2022.905253 |
Ejemplares similares
-
Bronchiolitis Obliterans and Primary Ciliary Dyskinesia: What Is the Link?
por: Caballero-Colón, Ninoshka M, et al.
Publicado: (2021) -
The value of nasal nitric oxide measurement in the diagnosis of primary ciliary dyskinesia
por: Zhang, Xiang, et al.
Publicado: (2019) -
Novel compound heterozygous CCDC40 mutations in a familial case of primary ciliary dyskinesia
por: Zhao, Liqing, et al.
Publicado: (2022) -
The Short Term Influence of Chest Physiotherapy on Lung Function Parameters in Children With Cystic Fibrosis and Primary Ciliary Dyskinesia
por: Vandervoort, Bjarne, et al.
Publicado: (2022) -
Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies
por: Mirra, Virginia, et al.
Publicado: (2017)